###### Strengths and limitations of this study

-   This is the first study to establish optimal cut-off values for waist circumference for Qataris, which is a crucial criterion for a realistic estimation of the prevalence of metabolic syndrome in this population.

-   The study is based on a WHO STEPS survey, a well-established and tested method specifically for chronic non-communicable diseases (NCD) risk factor surveillance.

-   As for any population survey, the assumption is made that the sample of individuals interviewed is representative of the whole population.

Introduction {#s1}
============

Metabolic syndrome is a combination of individual risk factors that are associated with several serious health conditions such as diabetes, cardiovascular disease or stroke. It is diagnosed by the presence of three or more of five risk factors: abdominal obesity, raised blood pressure (BP), raised fasting blood glucose, raised triglycerides and reduced high-density lipoprotein (HDL) cholesterol. The prevalence of metabolic syndrome is therefore highly dependent on the cut-off points used for the definition of each single component of metabolic syndrome, and particularly for the definition of abdominal obesity. Abdominal obesity is normally measured by waist circumference and broad ethnic-group suboptimal cut-off points have been proposed.[@R1] [@R2] Until more specific data are available for Middle East countries, the International Diabetes Federation (IDF) recommended using European cut-off points for all Eastern Mediterranean and Middle East (Arab) populations.[@R1]

The aims of this study were: first, to confirm results from a previous study[@R3] showing that waist circumference was an appropriate measure of central obesity for the identification of metabolic syndrome among Qatari citizens; second, to assess optimal cut-off points for waist circumference in Qataris from data in a representative National Health Survey; third, to use these cut-off points to determine the prevalence and fourth, the determinants of metabolic syndrome among Qatari citizens.

Materials and methods {#s2}
=====================

Survey instrument and sampling {#s2a}
------------------------------

Qatar had a total adult population of about 1.5 million inhabitants in 2010 comprising 240 000 Qatari Nationals (39% aged \<15, 58% aged 15--64 and 3% aged 65 or more).[@R4]

We obtained survey data from a random sample of 2496 adult Qatari citizens aged 18--64 that were collected during the year 2012 by the trained Qatar Supreme Council of Health staff based on the WHO\'s established method for estimating non-communicable diseases prevalence and risk factors, as part of surveillance.

The same standardised questions and protocols have been used in many WHO member countries for monitoring within-country trends and for making comparisons across countries. General details on the survey are available at the WHO website,[@R5] and country-specific details are available in a report from the Supreme Council of Health, Qatar.[@R6] Briefly, a two-stage sample design was used, selecting primary sampling units (PSUs) at the first stage and a sample of households within each selected PSU at the second stage. A total of 96 PSUs were selected from the Qatari frame of PSUs. In the second stage, 30 households were selected from each selected PSU by simple systematic sampling. Interviewers visited each selected household and identified all survey-eligible individuals. A personal digital assistant device was used to generate a random number to select one individual, either male or female, from within the household. Only these selected individuals were administered the questionnaire at their household. Since biomedical tests require 12 hours of fasting, appointments were given based on the agreement between the interviewers and the respondents and were conducted at the household level on Saturdays. In total 2496 of the 2850 Qatari households selected were interviewed, corresponding to an overall response rate of 88%. An Arabic standardised version of the stepwise data collection form (Questionnaire) was used in the survey, gathering: Demographic and behavioural risk factors: age, sex, years at school, tobacco and smokeless tobacco use, types of physical activity, sedentary behaviour, fruit and vegetable consumption, history of raised BP, history of diabetes and oral health;Physical measurements: height and weight, waist circumference, hip circumference, BP;Blood samples for biochemical measurements: fasting blood glucose, total cholesterol, HDL cholesterol, LDL-cholesterol and triglycerides.

All the Qatar national STEPwise questionnaires were tested for cultural applicability and sensitivity through word and pilot testing of the questionnaires.

This research proposal had been previously reviewed and approved by the Qatar Supreme Council of Health. The Office of Research Integrity at Weill Cornell Medical College in Qatar reviewed the proposal for secondary research analysis of those data by the authors and determined that such secondary analysis was exempt from Qatari and American human subject protection regulations and therefore did not require review by an institutional review board.

Definition of metabolic syndrome and physical activity assessment {#s2b}
-----------------------------------------------------------------

Metabolic syndrome was defined according to the IDF criteria.[@R1] It combines several individual risk factors including raised fasting blood glucose (≥100 mg/dL or taking diabetes medication), raised BP (systolic BP≥130 mm Hg or diastolic BP≥85 mm Hg, or taking anti-hypertensive medication), raised triglycerides (≥150 mg/dL), reduced HDL cholesterol (\<40 in men or \<50 mg/dL in women) and central obesity defined as waist circumference with ethnicity specific values (using Qatar-specific cut-offs estimated from this study: waist circumference ≥102 in men or ≥94 cm in women or body mass index (BMI)≥30 kg/m^2^). According to the IDF criteria,[@R1] if BMI is \>30 kg/m^2^, central obesity can be assumed and waist circumference does not need to be measured. If three or more of these risk factors are present, then metabolic syndrome is present.[@R1]

We calculated the total physical activity using the Global Physical Activity Questionnaire developed by the WHO.[@R7] This instrument collects information on physical activity participation in three settings (activity at work, travel to and from places, recreational activities) and sedentary behaviour. Participants were categorised into low, moderate and high levels of activity based on the sum of their total metabolic equivalent (MET)-minutes of activity computed for each setting (1 MET being defined as 1 kcal/kg/hour and is equivalent to the energy cost of sitting quietly).

Data analysis {#s2c}
-------------

Demographic and health characteristics of the Qatari population were evaluated using data from a cross-sectional WHO STEPwise survey conducted in 2012. The STEPS tool was designed to cover three levels of risk factor assessment: step 1---demographic and behavioural risk factors information, step 2---physical measurements in household settings and step 3---biochemical measurements. The data were weighted using population weights to adjust for age and sex differences between the sample and the national population. Percentages, means and corresponding 95% CIs were then calculated using the weighted data. Comparison of percentages across groups of participants was assessed using the Rao-Scott χ^2^ test, which is a design-adjusted version of the Pearson χ^2^ test.

We evaluated the prevalence of each single component of metabolic syndrome in men and women by different age groups. We used the receiver operator characteristic (ROC) curve analysis to assess the performance of various measures of obesity (BMI, waist circumference, waist-to-height ratio) for the identification of those with at least two other components of metabolic syndrome and calculated the area under the curve (AUC) (or 'c-statistic') to assess the prediction ability of each parameter. Optimal waist circumference cut-off points that maximise total accuracy (sensitivity and specificity) were calculated by the intersection of the plots of sensitivity and specificity separately for men and for women and combined with other measurements to assess the prevalence of metabolic syndrome in Qatar.

Finally, we searched for lifestyle factors associated with metabolic syndrome using logistic regression, adjusting models for potential confounders such as age, gender or educational attainment level. When present, missing data were treated as a separate category and represented by dummy variables, allowing logistic regression models to be fitted on the whole population.

Data analysis was performed using the SURVEYFREQ, SURVEYMEANS, SURVEYREG and SURVEYLOGISTIC procedures of the SAS software (V.9.2, Cary, North Carolina, USA). All tests were two-sided and p values \<0.05 considered statistically significant.

Results {#s3}
=======

The survey sample consisted of 1053 male and 1443 female Qataris. [Table 1](#BMJOPEN2015009514TB1){ref-type="table"} contains sociodemographic characteristics of participants according to gender. Significant gender-related differences were observed for educational attainment, with significantly more women (14.6%) than men (5.4%) who had attained less than primary school, for marital status with more women than men being divorced or widowed (6.4% and 3.9%, respectively, for women and 2.2% and 0.2% for men) and for occupation with the majority of men (64.7%) being government employees, while homemakers were the largest group in women (38.8%) (p\<0.0001). The age distribution (p=0.21) was similar in men and women.

###### 

Sociodemographic characteristics of participants according to gender

  --------------------------------------------------------------------------------------------------------
  Demographic information       Total (n=2496), %   Men (n=1053), %   Women (n=1443), %   Rao-Scott\
                                                                                          χ^2^ (p value)
  ----------------------------- ------------------- ----------------- ------------------- ----------------
                                100                 100               100                 

  Age group (years)                                                                       0.21

   18--29                       40.1                39.6              40.6                

   30--39                       25.7                27.5              24.0                

   40--49                       19.5                17.8              21.1                

   50--59                       11.1                11.0              11.2                

   60--64                       3.6                 4.1               3.1                 

  Educational attainment                                                                  **\<0.0001**

   Secondary school or more     67.0                67.4              66.7                

   Primary/preparatory school   22.8                27.1              18.7                

   Less than primary school     10.1                5.4               14.6                

  Marital status                                                                          **\<0.0001**

   Never married                29.8                30.1              29.5                

   Currently married            63.8                67.5              60.2                

   Divorced                     4.3                 2.2               6.4                 

   Widowed                      2.1                 0.2               3.9                 

  Occupation                                                                              **\<0.0001**

   Government employee          49.1                64.7              34.0                

   Non-government employee      5.6                 8.7               2.7                 

   Student                      13.4                11.3              15.5                

   Homemaker                    19.9                0.5               38.8                

   Retired                      7.5                 8.8               6.3                 

   Other                        4.4                 6.1               2.7                 
  --------------------------------------------------------------------------------------------------------

Best obesity measure that predicts metabolic syndrome {#s3a}
-----------------------------------------------------

We performed ROC curve analysis to determine which obesity measure (BMI, waist circumference or waist-to-height ratio) and the corresponding cut-off points that best predict metabolic syndrome. For this analysis, we plotted the sensitivity versus 1-specificity for all possible values of the three obesity measures to predict the presence of at least two of the four remaining factors of metabolic syndrome (raised BP, raised fasting blood glucose, raised triglycerides or reduced HDL cholesterol) ([figure 1](#BMJOPEN2015009514F1){ref-type="fig"}). Waist circumference and waist-to-height ratio were better predictors of metabolic syndrome than BMI in men and women, yielding respective moderate AUC of 0.612, 0.620 and 0.579 in men and 0.722, 0.728 and 0.685 in women. The classifier performance of waist circumference is, however, only poor in men and fair in women.

![Receiver operator characteristic (ROC) curves for body mass index, waist circumference and waist-to-height ratio to predict the presence of at least two factors of metabolic syndrome (excluding abdominal obesity) in men and women in Qatar. Information on body mass index was available for 2384 participants, waist circumference for 2335 participants and waist-to-height ratio for 2333 participants.](bmjopen2015009514f01){#BMJOPEN2015009514F1}

We therefore confirmed that waist circumference (criteria used by the IDF), which has similar predictive value of metabolic syndrome than waist-to-height ratio and necessitates a single measurement with no calculation, is an appropriate measure of central obesity. The waist circumference cut-off points that maximised total accuracy (sensitivity and specificity) were 102 for men and 94 cm for women, respectively. The corresponding sensitivity and specificity for the detection of metabolic syndrome were 57.8% and 58.4% in men and 65.7% and 66.7% in women.

Waist circumference distribution {#s3b}
--------------------------------

We assessed the waist circumference of Qatari men and women and the proportion of those with measures above cut-off points defined by the IDF in the absence of ethnic-specific values (≥94 for men and ≥80 cm for women), Adult Treatment Panel III (ATP-III) (≥102 for men and ≥88 cm for women) or obtained from the previous ROC curves analysis for Qatari citizens (≥102 for men and ≥94 cm for women) ([table 2](#BMJOPEN2015009514TB2){ref-type="table"}). Average waist circumference was 100 cm (95% CI 98 to 102) for men and 90 cm (95% CI 88 to 92) for women. Average waist circumference increased steadily with age in both sexes to reach 106 cm (95% CI 101 to 112) and 103 cm (95% CI 98 to 108), respectively, for men and women aged 60--64. Using the cut-off points proposed by the IDF (≥94 for men and ≥80 cm for women, ie, the same as those used for Europeans), 63.4% of men and 68.5% of women would be at risk, with the proportion as high as 77.1% in men and 92.4% in women aged 60 or more. Using the less-stringent ATP-III^2^ cut-off points (≥102 for men and ≥88 cm for women), the proportion of men and women with a waist circumference indicative of central obesity will diminish to 45.4% and 51.3%, respectively (for all age groups). Using Qatar-specific cut-off points identified by ROC curve analysis (≥102 for men and ≥94 cm for women), only 45.4% of men and 38.7% of women would be considered to have waist measurement indicative of central obesity.

###### 

Weighted prevalence of suboptimal waist circumference by sex and age group among Qataris using different cut-off points

                                             (95% CI)                                                                                                                     
  ----------------------------------- ------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------
  Men                                                                                                                                                                     
   Mean waist circumference           1021   100 cm (98 to 102)       94 cm (92 to 97)         102 cm (100 to 105)      103 cm (101 to 105)      107 cm (104 to 111)      106 cm (101 to 112)
   Proportion with waist ≥94 cm\*     686    63.4% (58.7% to 68.2%)   45.3% (38.2% to 52.3%)   69.7% (62.5% to 76.9%)   87.5% (72.2% to 84.7%)   84.6% (77.7% to 91.4%)   77.1% (60.1% to 94.2%)
   Proportion with waist ≥102 cm†,‡   480    45.4% (40.1% to 50.8%)   35.0% (28.1% to 41.9%)   46.8% (37.7% to 55.9%)   51.7% (43.5% to 59.9%)   61.8% (52.6% to 71.1%)   67.4% (49.3% to 85.5%)
  Women                                                                                                                                                                   
   Mean waist circumference           1314   90 cm (88 to 92)         80 cm (77 to 82)         92 cm (90 to 94)         98 cm (95 to 100)        102 cm (98 to 105)       103 cm (98 to 108)
   Proportion with waist ≥80 cm\*     985    68.5% (64.3% to 72.7%)   38.5% (30.9% to 46.0%)   80.3% (75.5% to 85.1%)   90.0% (85.2% to 94.7%)   93.3% (87.7% to 98.8%)   92.4% (83.8% to 100%)
   Proportion with waist ≥88 cm†      775    51.3% (47.3% to 55.3%)   24.7% (18.1% to 31.2%)   57.5% (51.5% to 63.6%)   70.2% (63.8% to 76.6%)   78.1% (70.3% to 85.9%)   85.9% (74.7% to 97.2%)
   Proportion with waist ≥94 cm‡      607    38.7% (34.7% to 42.7%)   17.4% (12.0% to 22.8%)   40.0% (33.2% to 46.7%)   54.3% (46.4% to 62.2%)   63.9% (55.0% to 72.9%)   77.2% (62.3% to 92.0%)

Information on waist circumference was available for 2335 participants.

\*International Diabetes Federation (IDF) values for Europeans.

†Adult Treatment Panel III (ATP)-III values for USA.

‡Qatar-specific values defined with receiver operator characteristic analysis.

Prevalence of metabolic syndrome {#s3c}
--------------------------------

The prevalence of metabolic syndrome and its components is presented in [table 3](#BMJOPEN2015009514TB3){ref-type="table"}, stratified by gender and age group. This information was collected at different steps of the survey and was available for a variable number of participants (1470 for fasting blood glucose, 2342 for BP, 1518 for triglycerides level, 1526 for HDL cholesterol and 2356 for abdominal obesity). As a result, information on metabolic syndrome was available for 1373 (55%) participants.

###### 

Weighted prevalence of metabolic syndrome and its components by sex and age group among Qataris

                                                        \% (95% CI)                                                                                                                  
  ----------------------------------------- ----------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ------------------------
  Both sexes (n=2496)                                                                                                                                                                
   Metabolic syndrome (≥3 risk factors)\*   430/1373    27.7% (24.5% to 30.9%)   9.3% (6.0% to 12.7%)     26.0% (19.8% to 32.3%)   37.9% (32.2% to 43.6%)   54.0% (45.2% to 62.7%)   70.2% (54.1% to 86.3%)
   Raised fasting blood glucose†            374/1470    22.5% (19.0% to 26.0%)   12.3% (7.9% to 16.8%)    15.7% (9.6% to 21.9%)    31.0% (24.7% to 37.4%)   44.7% (35.8% to 53.7%)   55.0% (40.3% to 69.7%)
   Raised BP‡                               1107/2432   42.7% (40.0% to 45.4%)   28.2% (23.7% to 32.6%)   36.2% (31.6% to 40.9%)   54.9% (50.2% to 59.6%)   73.9% (68.0% to 79.8%)   87.5% (78.4% to 96.7%)
   Raised triglycerides§                    270/1518    16.4% (13.7% to 19.0%)   9.0% (5.7% to 12.3%)     18.1% (12.7% to 23.5%)   20.6% (15.9% to 25.2%)   26.5% (18.0% to 35.0%)   24.2% (12.7% to 35.8%)
   Reduced HDL cholesterol¶                 676/1526    45.5% (41.3% to 49.8%)   38.4% (31.7% to 45.1%)   48.1% (40.8% to 55.3%)   49.1% (42.4% to 55.7%)   51.7% (43.7% to 59.7%)   62.3% (47.6% to 77.0%)
   Abdominal obesity\*\*                    1302/2356   50.6% (47.7% to 53.6%)   33.0% (28.1% to 37.9%)   54.2% (49.0% to 59.5%)   64.4% (59.7% to 69.2%)   68.9% (62.7% to 75.1%)   75.6% (64.0% to 87.3%)
  Men (n=1053)                                                                                                                                                                       
   Metabolic syndrome (≥3 risk factors)\*   179/538     28.7% (23.6% to 33.7%)   9.5% (4.4% to 14.6%)     26.4% (17.8% to 34.9%)   38.5% (30.2% to 46.9%)   62.3% (50.0% to 74.5%)   66.6% (42.0% to 91.2%)
   Raised fasting blood glucose†            152/552     23.1% (17.6% to 28.6%)   11.4% (6.0% to 16.9%)    13.6% (5.2% to 21.9%)    34.6% (24.3% to 44.9%)   50.8% (36.7% to 64.9%)   55.5% (32.3% to 78.6%)
   Raised BP‡                               470/1022    42.1% (38.5% to 45.6%)   25.8% (20.0% to 31.7%)   35.1% (28.3% to 41.9%)   54.5% (47.5% to 61.5%)   80.1% (73.2% to 86.9%)   86.9% (74.8% to 99.0%)
   Raised triglycerides§                    110/573     17.2% (13.0% to 21.3%)   6.5% (1.5% to 11.4%)     21.2% (12.7% to 29.7%)   20.4% (13.6% to 27.3%)   33.3% (19.2% to 47.3%)   25.4% (9.4% to 41.5%)
   Reduced HDL cholesterol¶                 290/575     51.9% (45.2% to 58.6%)   45.8% (34.9% to 56.7%)   53.8% (41.1% to 66.5%)   54.6% (45.8% to 63.5%)   56.7% (45.9% to 67.4%)   65.0% (43.6% to 86.3%)
   Abdominal obesity\*\*                    541/1031    50.7% (46.0% to 55.5%)   38.6% (31.2% to 46.0%)   54.9% (46.7% to 63.1%)   58.7% (50.9% to 66.5%)   64.2% (55.1% to 73.3%)   68.1% (50.1% to 86.0%)
  Women (n=1443)                                                                                                                                                                     
   Metabolic syndrome (≥3 risk factors)\*   251/835     26.8% (23.1% to 30.4%)   9.1% (4.2% to 14.0%)     25.6% (17.7% to 33.5%)   37.3% (28.6% to 46.0%)   46.7% (37.2% to 56.2%)   75.8% (59.0% to 92.6%)
   Raised fasting blood glucose†            222/918     21.9% (17.7% to 26.1%)   13.1% (7.1% to 19.2%)    18.2% (10.6% to 25.8%)   27.9% (20.3% to 35.6%)   39.5% (26.9% to 52.0%)   54.2% (34.5% to 74.0%)
   Raised BP‡                               637/1410    43.3% (38.9% to 47.6%)   30.3% (23.5% to 37.2%)   37.4% (30.3% to 44.4%)   55.2% (48.3% to 62.0%)   67.9% (60.5% to 75.3%)   88.3% (79.3% to 97.4%)
   Raised triglycerides§                    160/945     15.6% (12.6% to 18.6%)   11.2% (6.2% to 16.2%)    14.6% (8.8% to 20.4%)    20.7% (14.8% to 26.5%)   20.8% (13.2% to 28.3%)   22.3% (6.3% to 38.2%)
   Reduced HDL cholesterol¶                 386/951     39.4% (34.6% to 44.2%)   31.7% (24.4% to 39.0%)   41.5% (33.4% to 49.6%)   44.1% (35.3% to 52.9%)   47.4% (36.9% to 58.0%)   58.0% (37.7% to 78.3%)
   Abdominal obesity\*\*                    761/1325    50.5% (47.1% to 53.9%)   26.9% (20.9% to 33.0%)   53.5% (46.9% to 60.0%)   69.2% (63.6% to 74.8%)   73.6% (65.5% to 81.6%)   85.1% (73.7% to 96.5%)

\*Metabolic syndrome status could only be determined for 1373 participants (538 men, 835 women) having complete data for the five components.

†Raised fasting blood glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).

‡Raised BP (systolic BP≥130 or diastolic BP≥85 mm Hg or treatment of previously diagnosed hypertension).

§Raised triglycerides (≥150 mg/dL or specific treatment for this lipid abnormality).

¶Reduced HDL cholesterol (\<40 mg/dL in men; \<50 mg/dL in women or specific treatment for this lipid abnormality).

\*\*Abdominal obesity (waist ≥102 cm in men or ≥94 cm in women or BMI≥30 kg/m^2^).

BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein.

Considering all age groups together, reduced HDL cholesterol (51.9%) and abdominal obesity (50.7%) were the most common single components of metabolic syndrome in men, while abdominal obesity (50.5%) and raised BP (43.3%) were the most common single components of metabolic syndrome in women.

Overall, the prevalence of metabolic syndrome in Qatar based on country-specific estimates of waist circumference was 27.7% (95% CI 24.5% to 30.9%) for both sexes combined, 28.7% (95% CI 23.6% to 33.7%) in men and 26.8% (95% CI 23.1% to 30.4%) in women. This prevalence increases with age from 9.3% (95% CI 6.0% to 12.7%) in those under the age of 30 to 70.2% (95% CI 54.1% to 86.3%) in those aged 60--64.

Determinants of metabolic syndrome {#s3d}
----------------------------------

We used multivariable logistic regression to identify sociodemographic or lifestyle factors associated with metabolic syndrome ([table 4](#BMJOPEN2015009514TB4){ref-type="table"}). After adjustment for age and educational attainment level, gender was not associated with the risk of metabolic syndrome. The risk of metabolic syndrome, however, significantly increased with increasing age with OR=3.40 (95% CI 2.02 to 5.74); OR=5.66 (95% CI 3.65 to 8.78); OR=10.2 (95% CI 5.98 to 17.6) and OR=18.2 (95% CI 7.01 to 47.5) for those in the age group '30--39', '40--49', '50--59', '60--64' compared with those in the '18--29' age group (p\<0.0001), but decreased with increasing educational attainment with OR=0.61 (95% CI 0.39 to 0.96) for those who attained 'secondary school or more' compared with 'less than primary school' (p=0.03). No statistical significant association was observed for marital status or occupation. The particularly low but not statistically significant risk for students may be in part due to residual confounding from age, marital status and physical activity.

###### 

Characteristics associated with metabolic syndrome at multivariable analysis

  Characteristics\*                   Total   Percentage of participants with metabolic syndrome   OR (95% CI)†
  ----------------------------------- ------- ---------------------------------------------------- --------------------------
  All                                 1373    27.7                                                 
  Gender                                                                                           
   Men                                538     28.7                                                 1.00
   Women                              835     26.8                                                 0.83 (0.62 to 1.12)
  Age group (years)                                                                                
   18--29                             337     9.3                                                  1.00
   30--39                             353     26.0                                                 **3.40 (2.02 to 5.74)**
   40--49                             396     37.9                                                 **5.66 (3.65 to 8.78)**
   50--59                             214     54.0                                                 **10.25 (5.98 to 17.6)**
   60--64                             73      70.2                                                 **18.24 (7.01 to 47.5)**
  Education                                                                                        
   Less than primary school           169     50.0                                                 1.00
   Primary/preparatory school         312     30.3                                                 0.70 (0.39 to 1.26)
   Secondary school or more           891     23.3                                                 **0.61 (0.39 to 0.96)**
  Marital status                                                                                   
   Never married                      263     10.3                                                 1.00
   Currently married                  979     33.2                                                 1.40 (0.67 to 2.94)
   Divorced                           81      41.8                                                 1.97 (0.87 to 4.43)
   Widowed                            50      52.5                                                 1.73 (0.51 to 5.90)
  Occupation                                                                                       
   Government employee                631     24.2                                                 1.00
   Non-government employee            64      23.7                                                 1.07 (0.40 to 2.83)
   Student                            117     4.3                                                  0.38 (0.14 to 1.06)
   Homemaker                          354     37.6                                                 1.56 (0.94 to 2.59)
   Retired                            157     53.6                                                 1.53 (0.94 to 2.49)
  Tobacco smoking‡                                                                                 
   Never smoked tobacco               1126    28.1                                                 1.00
   Ever smoked tobacco                247     26.5                                                 0.76 (0.47 to 1.23)
   Currently smoke tobacco            195     23.7                                                 0.72 (0.47 to 1.12)
   Currently smoke daily tobacco      177     23.4                                                 0.71 (0.45 to 1.12)
  Physical activity                                                                                
   Low (\<600 MET-min/week)           643     31.9                                                 1.00
   Average (600--3000 MET-min/week)   304     29.3                                                 0.90 (0.64 to 1.28)
   High (≥3000 MET-min/week)          398     20.4                                                 **0.60 (0.42 to 0.86)**

Information on education was not available for 1 participant, occupation for 50 participants and physical activity for 28 participants.

\*Results are not presented when based on responses from \<30 participants.

†ORs and 95% CIs obtained from multivariable logistic regression model adjusted for age, sex and education level.

‡Any form of tobacco including cigarettes, cigars, pipe, Shisha or Medwakh.

Neither tobacco smoking nor any single component of the diet recorded at the survey (see online [supplementary table](#SM1){ref-type="supplementary-material"}) was associated with metabolic syndrome. After adjustment for age, gender and educational attainment, the risk of metabolic syndrome was reduced by 40% for those with high physical activity levels (at least 3000 MET-min/week) compared with those with low physical activity level (\<600 MET-min/week) (OR=0.60; 95% CI 0.42 to 0.86) (p=0.006).
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Metabolic syndrome among 'healthy' individuals {#s3e}
----------------------------------------------

The survey was conducted to be representative of the general population and therefore included a proportion of participants with previous diagnosis of diabetes or hypertension. Overall, 70% of the participants with available information about metabolic syndrome had never been previously told by a doctor or other health worker that they had either hypertension or diabetes. We reassessed the prevalence of metabolic syndrome and its components among these presumed 'healthy participants' ([table 5](#BMJOPEN2015009514TB5){ref-type="table"}). In this subset, the survey eventually found that 13.7% (95% CI 10.1% to 17.2%) had elevated fasting blood glucose, and 31.6% (95% CI 28.8% to 34.4%) had raised BP; metabolic syndrome was present in 16.5% (95% CI 13.5% to 19.5%).

###### 

Weighted prevalence of metabolic syndrome and its components by sex and age group among 1785 Qataris who reported not having been told by a doctor or other health worker that they had raised BP (or hypertension) or raised blood sugar (or diabetes)

                                                       \% (95% CI)                                                                                         
  ----------------------------------------- ---------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------
  Both sexes (n=1785)                                                                                                                                      
   Metabolic syndrome (≥3 risk factors)\*   177/963    16.5% (13.5% to 19.5%)   5.5% (2.6% to 8.4%)      22.0% (15.5% to 28.4%)   25.9% (19.5% to 32.3%)   31.3% (19.1% to 43.4%)
   Raised fasting blood glucose†            151/1042   13.7% (10.1% to 17.2%)   9.8% (5.4% to 14.3%)     13.6% (7.3% to 19.8%)    19.5% (13.7% to 25.3%)   20.8% (11.6% to 30.0%)
   Raised BP‡                               568/1733   31.6% (28.8% to 34.4%)   24.0% (19.9% to 28.1%)   31.5% (26.2% to 36.8%)   45.0% (39.2% to 50.8%)   48.2% (37.7% to 58.7%)
   Raised triglycerides§                    147/1077   12.4% (9.9% to 14.8%)    7.9% (4.6% to 11.2%)     15.6% (10.5% to 20.7%)   15.3% (10.4% to 20.3%)   19.8% (8.3% to 31.3%)
   Reduced HDL cholesterol¶                 441/1083   42.9% (38.1% to 47.8%)   38.3% (30.9% to 45.8%)   46.5% (38.5% to 54.5%)   47.9% (39.4% to 56.4%)   40.5% (29.1% to 51.9%)
   Abdominal obesity\*\*                    783/1666   43.8% (40.2% to 47.4%)   31.2% (25.8% to 36.6%)   51.2% (44.8% to 57.6%)   57.1% (51.1% to 63.1%)   61.4% (52.2% to 70.6%)
  Men (n=765)                                                                                                                                              
   Metabolic syndrome (≥3 risk factors)\*   81/390     17.6% (13.1% to 22.1%)   5.0% (1.1% to 8.8%)      24.1% (15.1% to 33.0%)   28.3% (19.0% to 37.6%)   34.3% (16.1% to 52.5%)
   Raised fasting blood glucose†            59/399     13.0% (7.9% to 18.1%)    7.4% (2.9% to 11.8%)     12.4% (3.7% to 21.1%)    22.9% (12.9% to 32.9%)   25.1% (9.3% to 40.9%)
   Raised BP‡                               243/741    30.3% (26.4% to 34.2%)   21.4% (15.4% to 27.4%)   30.7% (23.2% to 38.2%)   44.5% (36.1% to 52.9%)   51.5% (37.7% to 65.3%)
   Raised triglycerides§                    62/415     13.4% (9.2% to 17.7%)    6.3% (1.0% to 11.6%)     18.2% (9.7% to 26.7%)    18.7% (11.4% to 26.0%)   25.6% (5.5% to 45.7%)
   Reduced HDL cholesterol¶                 195/416    49.3% (41.1% to 57.4%)   44.7% (33.0% to 56.4%)   52.6% (39.1% to 66.1%)   53.0% (41.8% to 64.2%)   47.8% (28.5% to 67.1%)
   Abdominal obesity\*\*                    351/750    46.1% (40.6% to 51.6%)   38.2% (30.4% to 46.0%)   52.2% (43.3% to 61.2%)   53.9% (44.2% to 63.7%)   50.9% (36.4% to 65.3%)
  Women (n=1020)                                                                                                                                           
   Metabolic syndrome (≥3 risk factors)\*   96/573     15.3% (11.8% to 18.8%)   6.0% (2.1% to 10.0%)     19.0% (11.3% to 26.7%)   23.5% (14.8% to 32.3%)   29.2% (15.1% to 43.3%)
   Raised fasting blood glucose†            92/643     14.3% (10.0% to 18.6%)   12.0% (5.5% to 18.5%)    15.1% (8.1% to 22.0%)    16.2% (9.6% to 22.8%)    17.9% (5.9% to 29.9%)
   Raised BP‡                               325/992    32.9% (28.5% to 37.3%)   26.5% (20.2% to 32.7%)   32.4% (25.4% to 39.4%)   45.4% (37.6% to 53.3%)   45.8% (32.7% to 59.0%)
   Raised triglycerides§                    85/662     11.3% (8.2% to 14.3%)    9.4% (4.7% to 14.1%)     12.4% (7.4% to 17.4%)    12.1% (6.6% to 17.7%)    15.5% (4.2% to 26.8%)
   Reduced HDL cholesterol¶                 246/667    36.4% (30.9% to 41.9%)   32.5% (24.4% to 40.5%)   38.9% (30.1% to 47.6%)   43.0% (32.2% to 53.9%)   35.0% (20.9% to 49.2%)
   Abdominal obesity\*\*                    432/916    41.3% (37.6% to 45.1%)   23.4% (17.1% to 29.7%)   49.8% (43.0% to 56.6%)   60.0% (52.6% to 67.3%)   69.0% (56.2% to 82.0%)

Results for those aged 60--64 years are not presented because they are based on responses from \<30 participants.

\*Metabolic syndrome status could only be determined for 963 participants (390 men, 573 women) having complete data for the five components.

†Raised fasting blood glucose (≥100 mg/dL or previously diagnosed type 2 diabetes).

‡Raised BP (systolic BP≥130 or diastolic BP≥85 mm Hg or treatment of previously diagnosed hypertension).

§Raised triglycerides (≥150 mg/dL or specific treatment for this lipid abnormality).

¶Reduced HDL cholesterol (\<40 mg/dL in men; \<50 mg/dL in women or specific treatment for this lipid abnormality).

\*\*Abdominal obesity (waist ≥102 cm in men or ≥94 cm in women or BMI≥30 kg/m^2^).

BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein.

Discussion {#s4}
==========

Health professionals depend on estimates of the frequency of metabolic syndrome to plan effective strategies for controlling several serious conditions within a given population. Thus, it is extremely important that the estimated prevalence of metabolic syndrome be reliable and based on information that is appropriate for the selected region or country.

The major organisations concerned with defining metabolic syndrome recognise that central adiposity---an important component of this syndrome---is most easily measured by waist circumference.[@R1] [@R2] Furthermore, the IDF has emphasised the need for determining country-specific estimates of cut-off points for waist circumference in calculating the prevalence of metabolic syndrome. In fact, there is good evidence that body composition varies among ethnic groups, Asians having lower cut-off points than Europeans, and African-Americans and Hispanics having similar cut-off points to Europeans. Differences between populations could relate to genetic differences that may affect body composition, environmental exposure and particularly nutritional differences such as early childhood nutrition exposures.[@R8] A number of region-specific or population-specific estimates have been published, but there are only a few for Middle East countries and none for Qatar ([table 6](#BMJOPEN2015009514TB6){ref-type="table"}).

###### 

Ethnic specific values for waist circumference from selected Middle East countries

                 Ethnic specific values for waist circumference (cm)          
  -------------- ----------------------------------------------------- ------ ---------------------------
  Iran           89                                                    91     Delavari *et al*[@R11]
  Iran           94.5                                                  94.5   Hadaegh *et al*[@R12]
  Iran           92.6                                                  97.8   Talaei *et al*[@R13]
  Iran           92                                                    95     Mirmiran *et al*[@R14]
  Iran           94.5                                                  --     Gharipour *et al*[@R15]
  Iran           91.5                                                  85.5   Esteghamati *et al*[@R16]
  Iran, Kerman   89                                                    86     Gozashti *et al*[@R17]
  Iraq           97                                                    99     Mansour *et al*[@R18]
  Jordan         97.8                                                  95.6   Al-Odat *et al*[@R19]
  Omani Arabs    80                                                    84.5   Al-Lawati *et al*[@R20]
  Omani Arabs    78.5                                                  84.5   Al-Lawati *et al*[@R21]
  Egypt          93.5                                                  91.5   Ibrahim *et al*[@R22]
  Qatar          102                                                   94     Current study

In previous publications, Bener *et al*[@R3] [@R9] suggested that previous criteria for estimating the risk of metabolic syndrome as recommended by the WHO, the IDF and ATP-III might be inappropriate for Qatar. In particular, he and his coauthors proposed BMI, waist-to-hip and waist-to-height ratio in alternative to waist circumference as a measure of central obesity.[@R3] We used data from the 2012 Qatar National STEPwise Survey to calculate the current prevalence of metabolic syndrome in Qatar. We confirmed that waist circumference was an appropriate parameter for identifying other individual components of metabolic syndrome. For the entire Qatari adult population, using the best cut-off points for waist circumference, we estimate the prevalence of metabolic syndrome in adults to be 28%. This value resembles the previous overall estimate of 26% for this country obtained using the ATP-III criteria but considerably lower than the estimate of 37% derived from using the IDF criteria.[@R9] For comparison, estimates of the age-standardised prevalence of metabolic syndrome in the USA are 23%.[@R10]

In a multivariable analysis, the risk of metabolic syndrome increased steadily with age: participants aged 60--64 were 18 times more likely to suffer from metabolic syndrome than those who were in the 18--30 age group. The frequency of metabolic syndrome was 39% lower among participants with the highest level of educational attainment than in the group with the least amount of education. Exercise of at least 3000 MET-min/week lowered the risk of metabolic syndrome by 40% compared with persons in the lowest exercise group. Neither diet nor smoking had any impact on the occurrence of metabolic syndrome in this survey. This could be due to the fact that only basic information was collected on diet and because smoking prevalence is relatively low in Qatar. This analysis, however, suggests that among the various lifestyle factors that might alter the prevalence of metabolic syndrome in Qatar, exercise is the most important and deserves emphasis in any disease prevention programme.

Of interest, about 70% of participants in the sample survey were unaware of pre-existing diabetes or hypertension. After evaluation, 16.5% in this group were eventually diagnosed with metabolic syndrome.

The availability of specific waist circumference cut-off points for Qataris will also allow a better identification of the metabolic syndrome at the individual level in this population. Using lower cut-off points for Europeans, which are recommended in the absence of ethnicity specific data, would markedly increase the number of individuals classified at risk of Mets.

The strength of this study is that the data came from a carefully selected random population sample and data collection followed well-defined WHO criteria. As in other surveys, there was a different response rate for each step, especially for the collection of biological material. Fifty-five per cent of participants in the Qatar National STEPwise Survey provided a blood sample, which is still a fair response rate. Many individuals who live in this region refuse to provide blood samples for a variety of cultural reasons in survey situations such as this one, but we have no reason to believe that the blood sugar values of study participants who provided blood samples are different from the values of those who did not. However, this might introduce an unknown bias into the estimate of the prevalence of metabolic syndrome. We also recognised that treating missing data as a category in the regression models, as any other method to handle missing data, such as dropping subjects or imputation, could again have introduced some bias.

Another study limitation pertains to the accuracy of self-reported dietary information. This information is an estimate, which may not be a true measure of past or present food consumption. This could lead to inappropriate conclusions that the diet has no significant impact on prevention of metabolic syndrome. Finally, as for any population survey, the assumption was made that the sample of individuals interviewed is representative of the whole population. Our careful sampling framework should guarantee this assumption.

In summary, using new ethnic-specific cut-off points (≥102 for men and ≥94 cm for women) derived from the ROC curve analysis of abdominal waist circumference, the prevalence of metabolic syndrome in adult Qataris is 28%. We believe the new cut-off points for waist measurement from this country could be suitable for estimating the prevalence of metabolic syndrome in similar populations from other Middle East countries where country-specific data for waist measurements are unavailable.
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